SCHEMBL7692302

SCHEMBL7692302

Cc1ccccc1CNC(=O)C1CCC(Cc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.49
IDO1 P14902 1/20 0.49
LMNA P02545 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
THRB P10828 1/20 0.46
KMT2A Q03164 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
POLB P06746 1/20 0.46
HTR2B P41595 1/20 0.45
TP53 P04637 1/20 0.45
MAPT P10636 1/20 0.45
GRIN2B Q13224 1/20 0.45
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7691203 1.00 EPHX2 (0.49) EPHX2IDO1LMNASMN1; SMN2MEN1
SCHEMBL7690880 1.00 EPHX2 (0.49) EPHX2IDO1LMNASMN1; SMN2MEN1
SCHEMBL7693549 0.88 LMNA (0.60) IDO1LMNASMN1; SMN2MEN1ALDH1A1
SCHEMBL7689923 0.88 LMNA (0.60) IDO1LMNASMN1; SMN2MEN1ALDH1A1
SCHEMBL7088260 0.88 MAPK1 (0.53) IDO1LMNASMN1; SMN2ALDH1A1POLB
SCHEMBL7085312 0.88 MAPK1 (0.53) IDO1LMNASMN1; SMN2ALDH1A1POLB
SCHEMBL7085306 0.88 MAPK1 (0.53) IDO1LMNASMN1; SMN2ALDH1A1POLB
SCHEMBL7697784 0.87 HPGD (0.59) EPHX2LMNAMEN1ALDH1A1KMT2A
SCHEMBL7691193 0.87 HPGD (0.59) EPHX2LMNAMEN1ALDH1A1KMT2A
SCHEMBL7697935 0.86 HTR2B (0.51) IDO1LMNASMN1; SMN2POLBHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US claimed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US disclosed